Patients with testosterone deficiency syndrome and depression

Archivos Espanoles de Urologia

Volumn 66, Issue 7, 2013, Pages 729-736

  Khera, Mohit ^a,b  

^a Laboratory for Andrology Research   (United States)

^b Houston Hospital for Specialized Surgery   (United States)

Author keywords

Depression; Testosterone deficiency syndrome; Testosterone replacement therapy

Indexed keywords

ANDROGEN RECEPTOR; TESTOSTERONE;

AGED; ANDROGEN INSENSITIVITY SYNDROME; CASE REPORT; DEPRESSION; HORMONE SUBSTITUTION; HUMAN; MALE; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW;

AGED; ANDROGEN-INSENSITIVITY SYNDROME; DEPRESSION; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; RECEPTORS, ANDROGEN; TESTOSTERONE;

EID: 84883644875     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Lopez AD, Murray CC: The global burden of disease, 1990-2020. Nat Med 1998, 4:1241-3
2. Regier DA, Boyd JH, Burke JD, Jr. et al.: One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites. Arch Gen Psychiatry 1988, 45:977-86
3. Pirkola SP, Isometsa E, Suvisaari J et al.: DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population-results from the Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol 2005, 40:1-10
4. Pirkis J, Pfaff J, Williamson M et al.: The community prevalence of depression in older Australians. J Affect Disord 2009, 115:54-61
5. Mulligan T, Frick MF, Zuraw QC et al.: Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 2006, 60:762-9
6. Araujo AB, Esche GR, Kupelian V et al.: Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 2007, 92:4241-7
7. Zitzmann M: Testosterone and the brain. Aging Male 2006, 9:195-9
8. Khera M, Bhattacharya RK, Blick G et al.: The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS). Aging Male 2012, 15:14-21
9. Pope HG, Jr., Cohane GH, Kanayama G et al.: Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry 2003, 160:105-11
10. Zarrouf FA, Artz S, Griffith J et al.: Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract 2009, 15:289-305
11. Almeida OP, Waterreus A, Spry N et al.: One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology 2004, 29:1071-81
12. Schweiger U, Deuschle M, Weber B et al.: Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. Psychosom Med 1999, 61:292-6
13. Steiger A, von Bardeleben U, Wiedemann K et al.: Sleep EEG and nocturnal secretion of testosterone and cortisol in patients with major endogenous depression during acute phase and after remission. J Psychiatr Res 1991, 25:169-77
14. Seidman SN, Rabkin JG: Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression. J Affect Disord 1998, 48:157-61
15. Orengo CA, Fullerton L, Kunik ME: Safety and efficacy of testosterone gel 1% augmentation in depressed men with partial response to antidepressant therapy. J Geriatr Psychiatry Neurol 2005, 18:20-4
16. Pope HG, Jr., Amiaz R, Brennan BP et al.: Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment. J Clin Psychopharmacol 2010, 30:126-34
17. Araujo AB, Durante R, Feldman HA et al.: The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998, 60:458-65
18. T'Sjoen GG, De Vos S, Goemaere S et al.: Sex steroid level, androgen receptor polymorphism, and depressive symptoms in healthy elderly men. J Am Geriatr Soc 2005, 53:636-42
19. Dubrovsky BO: Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:169-92
20. Henderson LP, Penatti CA, Jones BL et al.: Anabolic androgenic steroids and forebrain GABAergic transmission. Neuroscience 2006, 138:793-9
21. Shores MM, Sloan KL, Matsumoto AM et al.: Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry 2004, 61:162-7
22. McEwen BS: Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 1991, 12:141-7
23. Shores MM, Moceri VM, Sloan KL et al.: Low testosterone levels predict incident depressive illness in older men: effects of age and medical morbidity. J Clin Psychiatry 2005, 66:7-14
24. Schutter DJ, Peper JS, Koppeschaar HP et al.: Administration of testosterone increases functional connectivity in a cortico-cortical depression circuit. J Neuropsychiatry Clin Neurosci 2005, 17:372-7
25. Tichomirowa MA, Keck ME, Schneider HJ et al.: Endocrine disturbances in depression. J Endocrinol Invest 2005, 28:89-99
26. Schneider G, Nienhaus K, Gromoll J et al.: Depressive symptoms in men aged 50 years and older and their relationship to genetic androgen receptor polymorphism and sex hormone levels in three different samples. Am J Geriatr Psychiatry 2011, 19:274-83
27. Sankar JS, Hampson E: Testosterone levels and androgen receptor gene polymorphism predict specific symptoms of depression in young men. Gend Med 2012, 9:232-43
28. Seidman SN, Araujo AB, Roose SP et al.: Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men. Biol Psychiatry 2001, 50:371-6
29. Margolese HC: The male menopause and mood: testosterone decline and depression in the aging male-is there a link? J Geriatr Psychiatry Neurol 2000, 13:93-101
30. Cavallini G, Caracciolo S, Vitali G et al.: Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging. Urology 2004, 63:641-6
31. Perry PJ, Yates WR, Williams RD et al.: Testosterone therapy in late-life major depression in males. J Clin Psychiatry 2002, 63:1096-101.
32. Morales AJ, Nolan JJ, Nelson JC et al.: Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994, 78:1360-7
33. Aydogan U, Aydogdu A, Akbulut H et al.: Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions. Endocr J 2012
34. Giltay EJ, Tishova YA, Mskhalaya GJ et al.: Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome. J Sex Med 2010, 7:2572-82
35. Bercea RM, Patacchioli FR, Ghiciuc CM et al.: Serum testosterone and depressive symptoms in severe OSA patients. Andrologia 2012
36. Shores MM, Kivlahan DR, Sadak TI et al.: A randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression). J Clin Psychiatry 2009, 70:1009-16.